Stock Market News
Latest financial news · Updated May 23, 2026
Unilever (UL) Reportedly Explores Food Business Spin-Off and Combination with McCormick
The panel is divided on the proposed Unilever-McCormick tie-up, with some seeing it as a value-unlocking move to refocus Unilever …
RBC Capital Raises its Price Target on nVent Electric plc (NVT) to $143 from $138
The panelists generally agree that NVT's growth prospects are tied to its liquid cooling and data center exposure, but there's …
Citi Raises its Price Target on Rentokil Initial plc (RTO) to 575 GBp from 550 GBp
Panelists debate Rentokil's turnaround potential, with mixed views on its growth prospects and margin expansion. While some see a re-rating …
Jefferies Downgrades Immunocore Holdings plc (IMCR) to Hold with a $33 Price Target
The panel consensus is that Immunocore's stock lacks a clear catalyst for re-rating, with Kimmtrak's uveal melanoma sales nearing peak …
Stock market today: Dow, S&P 500, Nasdaq rise amid hopes of US-Iran talks, oil falls below $100
The panel discussed the market's reaction to a peace proposal, with mixed views on the sustainability of the rally. While …
Victory Capital Withdraws its Proposal to Acquire Janus Henderson (JHG)
The withdrawal of Victory Capital simplifies the Trian/General Catalyst buyout of Janus Henderson, with a $52 offer price representing a …
Klarna Group (KLAR) Announces Klarna Card Reaches 5M Active Users Globally
Panelists agree that Klarna's user and merchant growth is impressive but not indicative of profitability. Key concerns include credit quality, …
ASOS Finds Its Fit Again
Panelists generally agree that ASOS's turnaround is not yet secure, with concerns about GMV decline, reliance on cost-cutting, and potential …
Codere Goes Up for Sale as Private Equity Cashes Out
Codere's sale faces significant headwinds due to regulatory risks, ESG constraints, and potential strategic buyer resistance to the current valuation …
The Most Favored Nation Policy: early insights into Europe’s response
The panel generally agrees that the US Most-Favored-Nation (MFN) policy is causing a significant shift in pharmaceutical companies' launch strategies …
SpaceX IPO leaves some private share buyers unsure what they own
The panel consensus is that the secondary market for pre-IPO SpaceX shares poses significant risks, including opacity, high fees, potential …
Polymarket is 72% Sure That Goldman Will Lead SpaceX's IPO
The panel is neutral to bearish on SpaceX's rumored IPO, citing potential regulatory hurdles, high valuation, and risks related to …